Cargando…
Comparison of alpha 1- antitrypsin activity and phenotype in type 1 diabetic patients to healthy individuals
BACKGROUND AND AIMS: Alpha 1 antitrypsin (AAT) is an inhibitor of serine protease, which has shown anti-inflammatory reactions in a variety of diseases. It has been thought that that AAT plays a role in prolonging islet allograft survival, preventing the development of type 1 diabetes mellitus (T1DM...
Autores principales: | Ghoreishi, Atena Sadat, Mahmoodi, Mehdi, Khoshdel, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067227/ https://www.ncbi.nlm.nih.gov/pubmed/35516706 http://dx.doi.org/10.4103/jfmpc.jfmpc_905_21 |
Ejemplares similares
-
Better isolation, proliferation and differentiation of human adipose-derived mesenchymal stem cells using human serum
por: Ghoreishi, Atena Sadat, et al.
Publicado: (2023) -
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
por: Park, Sangmi S., et al.
Publicado: (2021) -
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018) -
Alpha-1-antitrypsin phenotypes in adult liver disease patients
por: Topic, Aleksandra, et al.
Publicado: (2009) -
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
por: Al Ashry, Haitham S., et al.
Publicado: (2017)